The Onyx Pharmaceuticals (NASDAQ:ONXX) Corporate
Conference Call took place on 16-Feb-06 5:00pm ET.
ONXX reported no revenue for 4Q05 and $1m for the 12-month period ended 12/31/05. Net loss was $38.4m or $1 per share for the three months ended 12/31/05, and a net loss of $95.2m or $2.64 per share for the 12 months ended 09/31/05. Given Nexavars recent launch as well as the evolving competitive landscape, ONXX is not giving 2006 revenue guidance.
More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/80758
This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session.
ONXX reported no revenue for 4Q05 and $1m for the 12-month period ended 12/31/05. Net loss was $38.4m or $1 per share for the three months ended 12/31/05, and a net loss of $95.2m or $2.64 per share for the 12 months ended 09/31/05. Given Nexavars recent launch as well as the evolving competitive landscape, ONXX is not giving 2006 revenue guidance.
More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/80758
This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session.
© 2006 Business Wire
